Different Bupivacaine Volumes in Infiltration Between Popliteal Artery and Capsule of Knee Block

NACompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

April 20, 2024

Conditions

Pain, Postoperative

Interventions

DRUG

Bupivacaine 0.25% Preservative-Free Injectable Solution

local anesthetic drug injection for postoperative pain

Trial Locations (1)

Kasr Alainy hospitals, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT05438992 - Different Bupivacaine Volumes in Infiltration Between Popliteal Artery and Capsule of Knee Block | Biotech Hunter | Biotech Hunter